Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 13.


Griffiths, Gareth O, FitzGerald, Richard, Jaki, Thomas, Corkhill, Andrea, Reynolds, Helen ORCID: 0000-0001-7443-4520, Ewings, Sean, Condie, Susannah, Tilt, Emma, Johnson, Lucy, Radford, Mike
et al (show 27 more authors) (2021) AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. TRIALS, 22 (1). 487-.


Bosworth, Andrew, Rickett, Natasha Y, Dong, Xiaofeng, Ng, Lisa FP ORCID: 0000-0003-4071-5222, Garcia-Dorival, Isabel ORCID: 0000-0002-5654-5662, Matthews, David A, Fletcher, Tom, Jacobs, Michael, Thomson, Emma C, Carroll, Miles W
et al (show 1 more authors) (2021) Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care. GENOME MEDICINE, 13 (1). 5-.


Adler, Hugh, Gould, Susan, Hine, Paul, Snell, Luke B, Wong, Waison, Houlihan, Catherine F, Osborne, Jane C, Rampling, Tommy, Beadsworth, Mike Bj, Duncan, Christopher Ja
et al (show 14 more authors) (2022) Clinical features and management of human monkeypox: a retrospective observational study in the UK. LANCET INFECTIOUS DISEASES, 22 (8). pp. 1153-1162.


Mathioudakis, Alexander G, Abroug, Fekri, Agusti, Alvar, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy, Cadus, Cordula
et al (show 36 more authors) (2020) Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol. ERJ OPEN RESEARCH, 6 (3). pp. 193-2020.


Mathioudakis, Alexander G, Abroug, Fekri, Agusti, Alvar, Ananth, Sachin, Bakke, Per, Bartziokas, Konstantinos, Beghe, Bianca, Bikov, Andras, Bradbury, Thomas, Brusselle, Guy
et al (show 38 more authors) (2022) ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations. EUROPEAN RESPIRATORY JOURNAL, 59 (5). 2102006-.


Niemi, Mari EK, Karjalainen, Juha, Daly, Mark, Ganna, Andrea, Mehtonen, Juha, Cordioli, Mattia, Kaunisto, Mari, Pigazzini, Sara, Donner, Kati, Kivinen, Katja
et al (show 3481 more authors) (2021) Mapping the human genetic architecture of COVID-19. NATURE, 600 (7889). 472-+.


Khoo, Saye H ORCID: 0000-0002-2769-0967, FitzGerald, Richard, Saunders, Geoffrey, Middleton, Calley, Ahmad, Shazaad, Edwards, Christopher J, Hadjiyiannakis, Dennis, Walker, Lauren ORCID: 0000-0002-3827-4387, Lyon, Rebecca, Shaw, Victoria ORCID: 0000-0002-0429-0186
et al (show 80 more authors) (2022) Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial. The Lancet Infectious Diseases, 23 (2). pp. 183-195.


Walker, Lauren E ORCID: 0000-0002-3827-4387, FitzGerald, Richard, Saunders, Geoffrey, Lyon, Rebecca, Fisher, Michael, Martin, Karen, Eberhart, Izabela, Woods, Christie, Ewings, Sean, Hale, Colin
et al (show 23 more authors) (2022) An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2. CLINICAL PHARMACOLOGY & THERAPEUTICS, 111 (3). pp. 585-594.


Khoo, Saye H ORCID: 0000-0002-2769-0967, Fitzgerald, Richard, Fletcher, Thomas, Ewings, Sean, Jaki, Thomas, Lyon, Rebecca, Downs, Nichola, Walker, Lauren ORCID: 0000-0002-3827-4387, Tansley-Hancock, Olana, Greenhalf, William
et al (show 28 more authors) (2021) Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (12). pp. 3286-3295.


Relph, Katharine A, Russell, Clark D, Fairfield, Cameron J, Turtle, Lance, de Silva, Thushan I, Siggins, Matthew K, Drake, Thomas M, Thwaites, Ryan S, Abrams, Simon, Moore, Shona C
et al (show 358 more authors) (2022) Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission. Open Forum Infectious Diseases, 9 (5). ofac179-.


Killingley, Ben, Mann, Alex, Kalinova, Mariya ORCID: 0000-0002-3744-4604, Boyers, Alison, Goonawardane, Niluka ORCID: 0000-0003-2906-5513, Zhou, Jie, Lindsell, Kate, Hare, Samanjit, Brown, Jonathan ORCID: 0000-0001-6849-3962, Frise, Rebecca
et al (show 21 more authors) (2022) Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge. ResearchSquare.


Killingley, Ben, Mann, Alex J, Kalinova, Mariya, Boyers, Alison, Goonawardane, Niluka, Zhou, Jie, Lindsell, Kate, Hare, Samanjit S, Brown, Jonathan, Frise, Rebecca
et al (show 21 more authors) (2022) Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. NATURE MEDICINE, 28 (5). 1031-+.


Vaughan, Aisling, Aarons, Emma, Astbury, John, Balasegaram, Sooria, Beadsworth, Mike, Beck, Charles R, Chand, Meera, O'Connor, Catherine, Dunning, Jake, Ghebrehewet, Sam
et al (show 19 more authors) (2018) Two cases of monkeypox imported to the United Kingdom, September 2018. EUROSURVEILLANCE, 23 (38). pp. 2-6.

This list was generated on Sat Jan 20 09:10:47 2024 GMT.